Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD

Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disorder, and yet with no pharmacological treatment approved worldwide. The repositioning of old drugs provides a safe approach for drug development. Vidofludimus, an inhibitor for dihydroorotate dehydrogenase (DHODH)...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanlin Zhu (Author), Shuangshuang Xu (Author), Yi Lu (Author), Yijuan Wei (Author), Benqiang Yao (Author), Fusheng Guo (Author), Xing Zheng (Author), Yumeng Wang (Author), Ying He (Author), Lihua Jin (Author), Yong Li (Author)
Format: Book
Published: Frontiers Media S.A., 2020-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available